VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 634 filers reported holding VANECK VECTORS ETF TR in Q3 2022. The put-call ratio across all filers is 0.65 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $148 | -10.3% | 5,498 | 0.0% | 0.01% | -12.5% |
| Q2 2023 | $165 | -7.3% | 5,498 | 0.0% | 0.02% | -15.8% |
| Q1 2023 | $178 | +13.4% | 5,498 | 0.0% | 0.02% | +46.2% |
| Q4 2022 | $157 | -100.0% | 5,498 | -58.0% | 0.01% | -75.0% |
| Q3 2022 | $315,000 | +108.6% | 13,085 | +138.0% | 0.05% | +160.0% |
| Q2 2022 | $151,000 | -50.5% | 5,498 | -30.8% | 0.02% | -41.2% |
| Q1 2022 | $305,000 | +20.1% | 7,941 | 0.0% | 0.03% | +9.7% |
| Q4 2021 | $254,000 | +8.5% | 7,941 | 0.0% | 0.03% | 0.0% |
| Q3 2021 | $234,000 | -13.3% | 7,941 | 0.0% | 0.03% | -22.5% |
| Q2 2021 | $270,000 | – | 7,941 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |